Evaluation of Antimicrobial Susceptibility Among Acintobacter baumannii by E-Test Method at Khatam-Al-Anbia Hospital During 2013 - 2015

Authors Information
Article Notes and Dates
Abstract
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Hancock RE. Resistance mechanisms in Pseudomonas aeruginosa and other nonfermentative gram-negative bacteria. Clin Infect Dis. 1998; 27 Suppl 1: 93-9[PubMed]
  • 2. Liassine N. [Problems of antibiotic-resistance Gram negative pathogens in the hospital environment]. Schweiz Med Wochenschr. 2000; 130(50): 1930-6[PubMed]
  • 3. Fresnadillo-Martinez MJ, Garcia-Merino E, Garcia-Sanchez E, Martin-del Rey A, Rodriguez-Encinas A, Rodriguez-Sanchez G, et al. [Prevention of an outbreak of Acinetobacter baumannii in intensive care units: study of the efficacy of different mathematical methods]. Rev Esp Quimioter. 2015; 28(1): 10-20[PubMed]
  • 4. Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007; 5(12): 939-51[DOI][PubMed]
  • 5. Chu YW, Leung CM, Houang ET, Ng KC, Leung CB, Leung HY, et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol. 1999; 37(9): 2962-7[PubMed]
  • 6. Yadegarinia D, Abedy SH, Gachkar L, Rahmati Roodsari S. Prevalence and drug resistance of Acinetobacter baoumanii in ICU of teaching hospital. J Appl Environ Biol Sci. 2013; 3(9): 22-7
  • 7. Gaynes R, Edwards JR, National Nosocomial Infections Surveillance S. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005; 41(6): 848-54[DOI][PubMed]
  • 8. Kanafani ZA, Kara L, Hayek S, Kanj SS. Ventilator‐associated pneumonia at a tertiary‐care center in a developing country: Incidence, microbiology, and susceptibility patterns of isolated microorganisms •. Infect Control Hosp Epidemiol. 2003; 24(11): 864-9[DOI]
  • 9. Yadegarynia D, Azad MK, Gachkar L, Roodsari SR, Arab-Mazar Z. Drug resistance of acinetobacter in selected hospitals. Novel biomed. 2015; 3(3): 103-10
  • 10. Bergogne-Berezin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev. 1996; 9(2): 148-65[PubMed]
  • 11. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004; 39(3): 309-17[DOI][PubMed]
  • 12. Falagas ME, Rafailidis PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue. Crit Care. 2007; 11(3): 134[DOI][PubMed]
  • 13. Isolation of 100 multi drug resistant (mdr) acinetobacter baumannii in two tertiary care hospitals in tehran, iran. 46th Annual Meeting.
  • 14. Forbes BA, Sahm DF, Weissfeld AS. Study guide for Bailey and Scott's diagnostic microbiology. 2016;
  • 15. Kempf M, Rolain JM. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options. Int J Antimicrob Agents. 2012; 39(2): 105-14[DOI][PubMed]
  • 16. Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, et al. Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother. 2002; 49(3): 479-87[PubMed]
  • 17. Reddy T, Chopra T, Marchaim D, Pogue JM, Alangaden G, Salimnia H, et al. Trends in antimicrobial resistance of Acinetobacter baumannii isolates from a metropolitan Detroit health system. Antimicrob Agents Chemother. 2010; 54(5): 2235-8[DOI][PubMed]
  • 18. Wareham D, Bean D. Molecular typing of multi-drug resistant Acinetobacter baumannii from London hospitals. Int J Infect Dis. 2010; 14: 36[DOI]
  • 19. Feizabadi MM, Fathollahzadeh B, Taherikalani M, Rasoolinejad M, Sadeghifard N, Aligholi M, et al. Antimicrobial susceptibility patterns and distribution of blaOXA genes among Acinetobacter spp. Isolated from patients at Tehran hospitals. Jpn J Infect Dis. 2008; 61(4): 274-8[PubMed]
  • 20. Peymani A, Nahaei MR, Farajnia S, Hasani A, Mirsalehian A, Sohrabi N, et al. High prevalence of metallo-beta-lactamase-producing acinetobacter baumannii in a teaching hospital in Tabriz, Iran. Jpn J Infect Dis. 2011; 64(1): 69-71[PubMed]
  • 21. Taherikalani M, Fatolahzadeh B, Emaneini M, Soroush S, Feizabadi MM. Distribution of different carbapenem resistant clones of Acinetobacter baumannii in Tehran hospitals. New Microbiol. 2009; 32(3): 265-71[PubMed]
  • 22. Lin MF, Lan CY. Antimicrobial resistance in Acinetobacter baumannii: From bench to bedside. World J Clin Cases. 2014; 2(12): 787-814[DOI][PubMed]
  • 23. Abbasi F, Khalili-azad M, Asadi S, Yadegarynia D, Gholamin S, Gachkar L. Acinetobacter baumanii and nonbaumanii in iran, evaluation of antibiotic resistance. Iran J Public Health. 2014; 43(2): 35
  • 24. Yadegarynia D, Arab-Mazar Z. Evaluation of antimicrobial susceptibility among enterococcus species by e-test method at khatam-ol-anbia hospital during 2013 – 2014. Arch Clin Infect Dis. 2016; 11(1)[DOI]

Zahedan Journal of Research in Medical Sciences accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check